Trey D Lott, MD | |
2010 Patton Chapel Rd, Suite 201, Hoover, AL 35216-5782 | |
(205) 822-3333 | |
Not Available |
Full Name | Trey D Lott |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 2010 Patton Chapel Rd, Hoover, Alabama |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578616157 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 19369 (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Trey D Lott, MD 1011 Greymoor Rd, Shoal Creek, AL 35242-7210 Ph: (205) 991-5577 | Trey D Lott, MD 2010 Patton Chapel Rd, Suite 201, Hoover, AL 35216-5782 Ph: (205) 822-3333 |
News Archive
In four separate pivotal clinical studies presented on Friday, a greater percentage of moderate to severe chronic plaque psoriasis patients treated with briakinumab, Abbott's investigational IL-12/23 inhibitor (ABT-874), achieved 75 percent or better skin clearance rates than those treated with etanercept (EnbrelĀ®), methotrexate or placebo. Abbott presented data from all briakinumab pivotal studies in psoriasis at the European Association of Dermatology and Venereology scientific sessions.
Public affairs experts say easy and constant access by citizens to important government information, referred to as government transparency, is vital for good governance as well as the perception by citizens that the government is trustworthy.
A new study published in the journal Nature Climate Change on November 25, 2019, says that women may be unable to change their mode of survival to adapt to climate change and resulting alterations in socioeconomic and cultural conditions. The factors responsible for this difficulty may include migration of male family members and unfavourable working conditions, abetted by governmental failure to support them, or poverty.
Sound Pharmaceuticals (SPI) will begin recruiting a new clinical trial testing the oral drug SPI-1005 to prevent the hearing loss induced by loud music. Exposure to loud music or noise can induce temporary and permanent auditory threshold shifts (TTS or PTS). In some people, a repeated TTS will ultimately give way to a PTS that is irreversible.
Following the completion of its merger with Schering-Plough, Merck today confirms and underscores its commitment to marketing and developing cardiovascular medicines for a range of cardiovascular disorders.
› Verified 3 days ago
Tom Welch, MD General Practice Medicare: Medicare Enrolled Practice Location: 5608 Fairway Ct, Hoover, AL 35244 Phone: 205-733-1733 Fax: 205-733-1733 |